Multichannel perimetric alterations in systemic lupus erythematosus treated with hydroxychloroquine.

David P Piñero, Begoña Monllor, Vicente J Camps, Dolores de Fez

Open access · goldAbstract readCase Reports

In one paragraph

Article in Journal of optometry. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.6field-weighted citation impact, top 29% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David P PiñeroGrupo de Óptica y Percepción Visual (GOPV), Department of Optics, Pharmacology and Anatomy, University of Alicante, Spain; Department of Ophthalmology (OFTALMAR), Medimar International Hospital, Alicante, Spain; Foundation for the Visual Quality (Fundación para la Calidad Visual, FUNCAVIS), Alicante, Spain.

Begoña MonllorGrupo de Óptica y Percepción Visual (GOPV), Department of Optics, Pharmacology and Anatomy, University of Alicante, Spain.

Vicente J CampsGrupo de Óptica y Percepción Visual (GOPV), Department of Optics, Pharmacology and Anatomy, University of Alicante, Spain.

Dolores de FezGrupo de Óptica y Percepción Visual (GOPV), Department of Optics, Pharmacology and Anatomy, University of Alicante, Spain. Electronic address: dolores.fez@ua.es.

University of Alicante · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a multiorgan autoimmune disease of unknown etiology with many clinical manifestations. We report the first case of SLE in which visual alterations were evaluated with multichannel perimetry. Some achromatic and color vision alterations may be present in SLE, especially when treated with hydroxychloroquine. The sensitivity losses detected in the chromatic channels in the central zone of the visual field were consistent with the results of the FM 100 Hue color test. Likewise, the multichannel perimetry detected sensitivity losses in the parafoveal area for both chromatic channels, especially for the blue-yellow.

Indexed as

Color Vision DefectsEnzyme InhibitorsFemaleHumansHydroxychloroquineLupus Erythematosus, SystemicMiddle AgedVisual FieldsVisual Field TestsEnzyme InhibitorsHydroxychloroquineContrast sensitivityHydroxychloroquine maculopathyLupus diseaseLupus eritematosoMaculopatía por hidroxicloroquinaMultichannel perimetryPerimetría multicanalSensibilidad al contrasteVías visualesVisual pathways

Identifiers

PMID27349992

DOI10.1016/j.optom.2016.04.001

PMCPMC5383461

OpenAlexW2473814235

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC-ND

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.